Overview
Left atrial abnormality encompasses structural and functional changes in the left atrium, often associated with conditions like atrial fibrillation, hypertension, and heart failure, impacting cardiac hemodynamics and increasing thromboembolic risk 1.Diagnosis
Echocardiography for structural assessment and functional evaluation 1.
Electrocardiogram (ECG) to identify atrial fibrillation or other arrhythmias 1.
Biomarkers such as B-type natriuretic peptide (BNP) for heart failure evaluation 1.
Holter monitoring for prolonged rhythm assessment 1.Management
Rate control with beta-blockers (e.g., metoprolol 1-2 mg/kg/day) or non-dihydropyridine calcium channel blockers (e.g., verapamil 5-15 mg TID) 1.
Rhythm control using antiarrhythmic drugs like class Ic (e.g., flecainide) or class III (e.g., amiodarone) 1.
Anticoagulation with warfarin (INR 2.0-3.0) or direct oral anticoagulants (DOACs) like apixaban or rivaroxaban for stroke prevention 1.Special Populations
Pregnancy: Limited data; anticoagulation choices favor DOACs over warfarin due to lower teratogenic risk 1.
Pediatrics: Management tailored to underlying cause; close monitoring required due to evolving anatomy 1.
Elderly: Increased focus on bleeding risk; careful selection of anticoagulants 1.
Comorbidities: Hypertension management crucial; consider heart failure-specific therapies alongside atrial abnormality treatments 1.Key Recommendations
Use echocardiography for initial structural and functional assessment of left atrial abnormality (Evidence: Moderate) 1.
Implement anticoagulation with DOACs as first-line for stroke prevention in most patients (Evidence: Moderate) 1.
Tailor rate control strategies based on patient comorbidities and tolerance, favoring beta-blockers or calcium channel blockers (Evidence: Moderate) 1.References
1 Tell RA, Harlen F. A review of selected biological effects and dosimetric data useful for development of radiofrequency safety standards for human exposure. The Journal of microwave power 1979. link